Lessons Learned From Implementing Prospective, Multicountry Mixed-Methods Evaluations for Gavi and the Global Fund.


Journal

Global health, science and practice
ISSN: 2169-575X
Titre abrégé: Glob Health Sci Pract
Pays: United States
ID NLM: 101624414

Informations de publication

Date de publication:
23 12 2020
Historique:
received: 30 03 2020
accepted: 30 09 2020
entrez: 28 12 2020
pubmed: 29 12 2020
medline: 26 10 2021
Statut: epublish

Résumé

As global health programs have become increasingly complex, corresponding evaluations must be designed to assess the full complexity of these programs. Gavi and the Global Fund have commissioned 2 such evaluations to assess the full spectrum of their investments using a prospective mixed-methods approach. We aim to describe lessons learned from implementing these evaluations. This article presents a synthesis of lessons learned based on the Gavi and Global Fund prospective mixed-methods evaluations, with each evaluation considered a case study. The lessons are based on the evaluation team's experience from over 7 years (2013-2020) implementing these evaluations. The Centers for Disease Control and Prevention Framework for Evaluation in Public Health was used to ground the identification of lessons learned. We identified 5 lessons learned that build on existing evaluation best practices and include a mix of practical and conceptual considerations. The lessons cover the importance of (1) including an inception phase to engage stakeholders and inform a relevant, useful evaluation design; (2) aligning on the degree to which the evaluation is embedded in the program implementation; (3) monitoring programmatic, organizational, or contextual changes and adapting the evaluation accordingly; (4) hiring evaluators with mixed-methods expertise and using tools and approaches that facilitate mixing methods; and (5) contextualizing recommendations and clearly communicating their underlying strength of evidence. Global health initiatives, particularly those leveraging complex interventions, should consider embedding evaluations to understand how and why the programs are working. These initiatives can learn from the lessons presented here to inform the design and implementation of such evaluations.

Identifiants

pubmed: 33361241
pii: GHSP-D-20-00126
doi: 10.9745/GHSP-D-20-00126
pmc: PMC7784079
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

771-782

Informations de copyright

© Carnahan et al.

Références

Health Policy Plan. 2020 Nov 1;35(Supplement_2):ii35-ii46
pubmed: 33156940
J Adv Nurs. 1998 Oct;28(4):882-90
pubmed: 9829678
Qual Health Res. 1999 Jan;9(1):26-44
pubmed: 10558357
Int J Qual Health Care. 2018 Apr 20;30(suppl_1):10-14
pubmed: 29873794
MMWR Recomm Rep. 1999 Sep 17;48(RR-11):1-40
pubmed: 10499397
BMJ Glob Health. 2019 Mar 22;4(2):e001369
pubmed: 30997172
Health Policy Plan. 2018 Apr 1;33(3):445-455
pubmed: 29365123
Bull World Health Organ. 2006 Aug;84(8):620-8
pubmed: 16917649
Lancet. 2001 Aug 11;358(9280):483-8
pubmed: 11513933
BMC Health Serv Res. 2014 Jan 03;14:2
pubmed: 24383766
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Health Policy Plan. 2014 May;29(3):323-7
pubmed: 23564372
Implement Sci. 2017 Feb 10;12(1):15
pubmed: 28187747
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Eur J Public Health. 2011 Aug;21(4):397-8
pubmed: 21771736
BMJ. 2004 Jun 19;328(7454):1490
pubmed: 15205295
Int J Health Policy Manag. 2016 Oct 26;6(6):327-338
pubmed: 28812825

Auteurs

Emily Carnahan (E)

PATH, Seattle, WA, USA. ecarnahan@path.org.

Nikki Gurley (N)

PATH, Seattle, WA, USA.

Gilbert Asiimwe (G)

Infectious Diseases Research Collaboration, Kampala, Uganda.

Baltazar Chilundo (B)

University of Eduardo Mondlane, Maputo, Mozambique.

Herbert C Duber (HC)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Department of Emergency Medicine, University of Washington, Seattle, WA, USA.

Adama Faye (A)

Institut de Santé et Développement/University Cheikh Anta Diop, Dakar, Senegal.

Carol Kamya (C)

Infectious Diseases Research Collaboration, Kampala, Uganda.

Godefroid Mpanya (G)

PATH, Kinshasa, Democratic Republic of the Congo.

Shakilah Nagasha (S)

Infectious Diseases Research Collaboration, Kampala, Uganda.

David Phillips (D)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Nicole Salisbury (N)

PATH, Seattle, WA, USA.

Jessica Shearer (J)

PATH, Seattle, WA, USA.

Katharine Shelley (K)

PATH, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH